BIO vs CEPO · rev $651.0M vs $271.1M cap
BIO (BIO) versus Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO) is a shell companies company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
CEPO does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. CEPO currently screens at market cap $271.1M.
Not investment advice. Open the BIO and CEPO stock pages for the full models.
Not investment advice.